Pfizer and BioNTech’s jointly developed COVID-19 vaccine was successful in neutralizing a new variant of the coronavirus spreading rapidly in Brazil, Reuters reports, citing the findings of a study conducted by scientists from the companies and the University of Texas Medical Branch.
Key takeaways
“Blood taken from people who had been given the vaccine neutralized an engineered version of the virus that contained the same mutations carried on the spike portion of the highly contagious P.1 variant first identified in Brazil.”
“The neutralizing ability was roughly equivalent to the vaccine’s effect on a previous less contagious version of the virus from last year.”
Previously, Pfizer has said it believes its current vaccine is highly likely to still protect against the South African variant.
Market implications
Encouraging vaccine news combined with the retreat in the US Treasury yields if boding well for the risk sentiment, as the Asian equities attempt a bounce while the S&P 500 futures extend gains towards 3,850.
The US dollar index takes a breather, easing off four-month tops at 92.50.
作者：Dhwani Mehta，文章來源FXStreet，版權歸原作者所有，如有侵權請聯繫本人刪除。
風險提示：本文所述僅代表作者個人觀點，不代表 Followme 的官方立場。Followme 不對內容的準確性、完整性或可靠性作出任何保證，對於基於該內容所採取的任何行為，不承擔任何責任，除非另有書面明確說明。
暫無評論，立馬搶沙發